Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yoshinori Hamajima"'
Autor:
Norimitsu TAKAHASHI, Shuichi KAI, Hisashi KOHMURA, Katsumi ISHIKAWA, Takashi TANAKA, Kohji KUROYANAGI, Yoshinori HAMAJIMA, Satoshi OHTA, Toshihito KADOTA, Shigeo KAWANO, Keiko OHTA, Yukako TAKEUCHI
Publikováno v:
The Journal of Toxicological Sciences. 11:263-279
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to male Crj : CD (Sprague-Dawley) rats for 61 days and to female rats of the same strain for 14 days prior to mating at dose levels of 0.05, 0.2 and 0.8 mg/kg/day.
Autor:
Katsumi Ishikawa, Kohji Kuroyanagi, Satoshi Ohta, Hirotaka Chikazawa, Yukako Takeuchi, Hisashi Kohmura, Norimitsu Takahashi, Toshihito Kadota, Shigeo Kawano, Keiko Ohta, Shuichi Kai, Yoshinori Hamajima
Publikováno v:
The Journal of Toxicological Sciences. 11:123-161
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to Crj : CD (Sprague-Dawley) rats of both sexes at dose levels of 0.05, 0.15, 0.5 and 1.5 mg/kg/day for three months with the object of examining its toxicity and
Autor:
Katsumi Ishikawa, Hisashi Kohmura, Satoshi Ohta, Yoshinori Hamajima, Keiko Ohta, Norimitsu Takahashi, Kohji Kuroyanagi, Shigeo Kawano, Shuichi Kai, Toshihito Kadota
Publikováno v:
The Journal of Toxicological Sciences. 11:17-49
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to Crj : CD (Sprague-Dawley) rats of both sexes at dose levels of 3, 10, 30 and 100 mg/kg/day for one month with the object of examining its subacute toxicity and the rev
Autor:
Kohji Kuroyanagi, Toshihito Kadota, Shigeo Kawano, Katsumi Ishikawa, Norimitsu Takahashi, Shuichi Kai, Keiko Ohta, Satoshi Ohta, Hisashi Kohmura, Yoshinori Hamajima
Publikováno v:
The Journal of Toxicological Sciences. 11:195-225
VP16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to pregnant Crj: CD (Sprague-Dawley) rats from day 7 through 17 of gestation at dose levels of 1, 3 and 10 mg/kg/day. The summarized results obtained are as follows: 1. VP
Autor:
Satoshi Ohta, Yoshinori Hamajima, Shuichi Kai, Katsumi Ishikawa, Shigeo Kawano, Hisashi Kohmura, Toshihito Kadota, Norimitsu Takahashi, Keiko Ohta, Kohji Kuroyanagi
Publikováno v:
The Journal of Toxicological Sciences. 11:89-122
VP16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to Crj : CD (Sprague-Dawley) rats of both sexes at dose levels of 0.15, 0.50, 1.5 and 4.5 mg/kg/day for one month with the object of examining its subacute toxicity
Autor:
Katsumi Ishikawa, Yoshinori Hamajima, Kohji Kuroyanagi, Satoshi Ohta, Norimitsu Takahashi, Toshihito Kadota, Shigeo Kawano, Keiko Ohta, Hisashi Kohmura, Shuichi Kai
Publikováno v:
The Journal of toxicological sciences. 11
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to Crj: CD (Sprague-Dawley) rats of both sexes at dose levels of 1, 3, 10 and 30 mg/kg/day for six months with the object of examining its chronic toxicity and the revers
Autor:
Yukako Takeuchi, Shigeo Kawano, Shuichi Kai, Toshihito Kadota, Kohji Kuroyanagi, Keiko Ohta, Satoshi Ohta, Katsumi Ishikawa, Norimitsu Takahashi, Hisashi Kohmura, Yoshinori Hamajima
Publikováno v:
The Journal of toxicological sciences. 11
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was examined for its oral, subcutaneous or intravenous acute toxicity using Slc : ICR mice, Crj : CD (Sprague-Dawley) rats and JW-NIBS rabbits of both sexes. The summarized results obtained are
Autor:
Norimitsu TAKAHASHI, Shuichi KAI, Hisashi KOHMURA, Katsumi ISHIKAWA, Kohji KUROYANAGI, Yoshinori HAMAJIMA, Satoshi OHTA, Toshihito KADOTA, Shigeo KAWANO, Keiko OHTA
Publikováno v:
The Journal of toxicological sciences. 11
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to pregnant JW-NIBS rabbits from day 6 through 18 of gestation at dose levels of 0.3, 1, 3 and 10 mg/kg/day. The summarized results obtained are as follows: VP 3 and 10 m
Autor:
Norimitsu TAKAHASHI, Shuichi KAI, Hisashi KOHMURA, Katsumi ISHIKAWA, Kohji KUROYANAGI, Yoshinori HAMAJIMA, Satoshi OHTA, Toshihito KADOTA, Shigeo KAWANO, Keiko OHTA, Yukako TAKEUCHI
Publikováno v:
The Journal of toxicological sciences. 11
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered intravenously to female Crj: CD (Sprague-Dawley) rats from day 17 of gestation through postpartum day 20 at dose levels of 0.05, 0.2 and 0.8 mg/kg/day. The summarized results ob
Autor:
Katsumi Ishikawa, Toshihito Kadota, Norimitsu Takahashi, Yoshinori Hamajima, Hisashi Kohmura, Satoshi Ohta, Shuichi Kai, Shigeo Kawano, Kohji Kuroyanagi, Keiko Ohta
Publikováno v:
The Journal of toxicological sciences. 11
VP 16-213 (etoposide, abbr. to VP), an oncostatic drug, was administered orally to female Crj: CD (Sprague-Dawley) rats from day 17 of gestation through postpartum day 20 at dose levels of 1, 3 and 10 mg/kg/day. The summarized results obtained are as